Cell Cycle Studies In Full Spin During The Last Few Years

While scientists have known for centuries that cells divide, only during the last couple of decades have researchers really begun to make progress in investigating the how's and why's of the division. Understanding the driving mechanisms involved--the chemical triggers-- will help scientists determine why this process sometimes goes wrong (as in the case of cancer cell growth) and, someday, may also spur the development of methods to prevent and reverse such malfunctions. Jonathon Pines, a visi

Written byAngela Martello
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The flurry of research on cell division was made possible by a union of several disciplines: yeast genetics, cell biology, and biochemistry. "Several different areas of research have converged," says Sergio Mor-eno, a postdoctoral research fellow at the University of Oxford. "Many people suddenly realized that they were working on the same thing."

Pines concurs: "Yeast geneticists realized they were working on the same protein as cell biologists who were working on extracts from cells because the biochemists came along and purified the proteins."

The proteins that these various research groups were (and still are) investigating are the components of maturation-promoting factor (MPF), a chemical signal that induces both meiotic and mitotic cell division. Two independent research groups--one from Yale University and one from Argonne National Laboratory--discovered MPF in the early 1970s. Further studies revealed that the amount of MPF in a cell rises and falls with each mitotic division. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies